Bailard »

Adma Biologics shares owned by Bailard

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Bailard

Quarter filed Position value Share count Share price at filing
2023-12-31 $110k 24k 4.52
2023-06-30 $100k 27k 3.69

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Fds Inf Tech Etf (VGT)
Spdr Ser Tr Nuveen Blmbrg Mu (TFI)
Gilead Sciences (GILD)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Pimco Etf Tr Inter Mun Bd Act (MUNI)
Visa Com Cl A (V)

View all positions for Bailard

Top funds holding Adma Biologics

Vanguard Group
D. E. Shaw & Co
Perceptive Advisors
AWM Investment Company
Dimensional Fund Advisors
Millennium Management
Assenagon Asset Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Oberweis Asset Management
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Tang Capital Management

View all funds holding Adma Biologics